The U.S. Environmental Protection Agency (EPA) has proposed sweeping regulations that would require states to reduce carbon dioxide emissions from the electricity sector by an average of 30 percent nationally. This costly plan is another step in the administration's policies designed to eliminate low cost and reliable electricity and replace it with more expensive and less reliable sources.
"The rule is a stunning attempt to remake the nation's entire electric grid at great cost to households and businesses across the US. Our manufacturing base will become less competitive because of higher electricity prices. The impact of this regulation will be felt by families as they will spend more to heat and cool their homes. Those on fixed incomes and seniors will be forced to pay a disproportionately higher share of their monthly budget on utilities," said Hal Quinn, president and CEO, National Mining Association."
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7221731-national-mining-association-americans-electricity-bill-increase-due-to-epa-regulations/
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today it has received U.S. Food and Drug Administration (FDA) approval for its newest innovative hearing loss solution, Kanso.
The Kanso Sound Processor provides a distinct new way for cochlear implant users to hear. Unlike most hearing aids and current cochlear implant sound processors that are worn on the ear, Kanso is a small, off-the-ear hearing device that provides a more discreet hearing solution and delivers the same hearing experience as a behind-the-ear sound processor.
The name Kanso is a Japanese word for ‘simplicity,’ and it was selected in recognition of Kanso’s all-in-one design. The Kanso Sound Processor features a single on/off button with no cables so it is easy to use. It is worn on the user’s head with nothing behind the ear, adding greater comfort for those with glasses, and it can be easily hidden under or blended within a user’s hair.
To view the multimedia release go to:
http://www.multivu.com/players/English/7658352-cochlear-kanso-fda-approval/
The U.S. Food and Drug Administration (FDA) is alerting pregnant women about the risks of listeriosis, a foodborne disease that can severely affect a pregnant women and her unborn child.
Listeria can affect all races and ethnic groups, but pregnant women are 10 times more likely than other healthy adults to get listeriosis due to hormonal changes that affect the immune system during pregnancy. Pregnant Hispanic women are about 24 times more likely than the general population to get listeriosis. A pregnant mother may pass Listeria onto her unborn baby without even knowing it because she doesn’t feel sick at all, yet the disease can lead to miscarriage, stillbirth, premature labor, the delivery of a low birthweight infant, a wide range of health problems for a newborn, or even infant death.
To view the multimedia release go to:
https://www.multivu.com/players/English/7953451-fda-listeriosis-prevention-pregnant-women/
Abbott today announced the U.S. Food and Drug Administration (FDA) approved the Masters HP™ 15mm rotatable mechanical heart valve, the world’s smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic valve replacement. Until today, surgeons could only use a range of larger-sized valves to replace a pediatric heart valve that could not be repaired, and larger valves are often not suitable given the smaller size of children’s hearts. This dime-sized new valve is the first and only pediatric mechanical heart valve developed for newborns and infants, and offers hope for pediatric patients in urgent need of treatment who have no other approved options.
To view the multimedia release go to:
https://www.multivu.com/players/English/8280551-abbott-pediatric-heart-valve-fda-approval/
The American Coalition for Clean Coal Electricity today released a new report “Energy Cost Impacts on Families” that details the plight of American households who are significantly harmed by rising energy costs.
The study finds that on average nearly half of America’s households are bringing home $1,900 a month, less than $23,000 annually, and spending 17 percent of those hard-earned dollars on energy. Low and fixed income families, including minorities and senior citizens, are among the most vulnerable to energy price increases and frequently must make tough choices about what to do to meet energy costs.
“No one should go without food or medication to keep the lights on but that’s exactly what is taking place in millions of households across America,” said Mike Duncan, president and CEO of ACCCE. “Regulations like EPA’s calamitous Clean Power Plan will only exacerbate the economic struggles families face, making it all that much harder to keep a roof over their heads and food on the table. This administration should put Americans ahead of its politically charged agenda and immediately take action to ensure vulnerable families are not harmed further by these reckless regulations.”
To view the Multimedia News Release, go http://www.multivu.com/players/English/7552751-accce-family-energy-impact-report/
India is one of the fastest growing economies in the world fueled by an economically progressive administration, an emerging IT sector, a burgeoning middle-class, and an ever-increasing base of skilled workers. In addition, with the demonetisation drive and the recent introduction of RERA and now GST, we believe, will all work favourably to bring about the much needed transparency in the sector and will benefit both customers and developers in the long run.
In the backdrop of the recent regulatory changes, we believe that the real estate sector in India is showing great promise and is poised for tremendous growth over the coming years.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8152451-godrej-india-time-to-shine-real-estate/
Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.*
To view the multimedia release go to:
https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
The egg has been regarded as a symbol of new life and has been associated with springtime celebrations, such as Easter and Passover, for many centuries. But, even during festive occasions, eggs can cause food poisoning (also called foodborne illness). That’s why the U.S. Food and Drug Administration reminds consumers to follow safe food handling practices when buying, storing, preparing, and serving eggs or foods that contain them during their springtime celebrations and throughout the year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7790251-fda-egg-safety/
Nearly three in four American voters (74 percent) favor increasing federal funding for cancer research, according to the results of a new national survey conducted on behalf of the American Association for Cancer Research (AACR). The survey results were released today in conjunction with the AACR’s fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to implement a strategy for providing annual budget increases of at least 7 percent for the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA) in fiscal year 2016 and thereafter.
The national survey, which was conducted by Hart Research Associates and Public Opinion Strategies, shows that five out of every six voters recognize what the AACR Cancer Progress Report 2015 details: that progress is being made against cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7613551-aacr-cancer-research-survey/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
As part of National Teen Driver Safety Week, the National Highway Traffic Safety Administration and the Ad Council announced today their first national public service campaign designed to prevent underage drinking and driving. Following the success of iconic campaigns including “Friends Don’t Let Friends Drive Drunk” and “Buzzed Driving is Drunk Driving,” the new public service ads (PSAs) were unveiled this morning by Mark Rosekind, Administrator for the U.S. Department of Transportation’s National Highway Traffic Safety Administration (NHTSA), at the National Organizations for Youth Safety (NOYS) Teen Safe Driving Summit in Washington, DC.
“One teenage death from drinking and driving is too many,” said NHTSA Administrator Mark Rosekind. “Our goal with this campaign is to raise awareness among teenagers that drinking and driving is one of the worst mistakes they can ever make, with deadly consequences that can’t be undone.”
Motor vehicle crashes are the leading cause of death among teens in America, and almost half of teens killed in crashes are the drivers themselves. Despite a minimum legal drinking age of 21 in all 50 states, almost one-quarter of young drivers involved in fatal traffic crashes had alcohol in their systems according to data from NHTSA.
To view the multimedia release go to:
http://www.multivu.com/players/English/7662551-ad-council-ultimate-party-foul/
